Neuro-Cardio-Autonomic Modulations in Children with Duchenne Muscular Dystrophy

被引:2
|
作者
Inbaraj, Ganagarajan [1 ]
Arjun, Krishnamurthy [2 ]
Meghana, Adoor [1 ]
Preethish-Kumar, Veeramani [3 ]
John, Anu P. [1 ]
Polavarapu, Kiran [3 ]
Nashi, Saraswati [3 ]
Sekar, Deepha [4 ]
Udupa, Kaviraja [1 ]
Prathuysha, Parthipulli, V [5 ]
Prasad, Krishna [1 ]
Bardhan, Mainak [3 ]
Raju, Trichur R. [1 ]
Kramer, Boris W. [6 ]
Nalini, Atchayaram [3 ]
Sathyaprabha, Talakad N. [1 ]
机构
[1] Natl Inst Mental Hlth & Neurosci, Dept Neurophysiol, Bangalore, Karnataka, India
[2] Dayananda Sagar Univ, Sch Engn, Dept CSE, Bangalore, Karnataka, India
[3] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore, Karnataka, India
[4] Natl Inst Mental Hlth & Neurosci, Dept Mol Genet, Bangalore, Karnataka, India
[5] Natl Inst Mental Hlth & Neurosci, Dept Biostat, Bangalore, Karnataka, India
[6] Maastricht Univ, Sch Mental Hlth & Neurosci, Med Ctr, Dept Paediat, Maastricht, Netherlands
关键词
Duchenne muscular dystrophy; autonomic modulation; heart rate variability; blood pressure variability; baroreflex sensitivity; HEART-RATE-VARIABILITY; DYSFUNCTION; CARDIOMYOPATHY; INFLAMMATION; INDEXES; REFLEX;
D O I
10.3233/JND-221621
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Objective: Duchenne muscular dystrophy (DMD) is a degenerative X-linked muscle disease. Death frequently results from complications in cardiopulmonary systems. Preclinical/early diagnosis of cardiac autonomic abnormalities may aid initiate cardioprotective therapy and enhance prognosis. Methods: A cross sectional, prospective study of 38 DMD boys compared with 37 age-matched healthy controls was conducted. Lead II electrocardiography and beat-to-beat blood pressure were recorded to assess heart rate variability (HRV), blood pressure variability (BPV), and baroreceptor sensitivity (BRS) in a standardized environment. Data were analysed and correlated with disease severity and genotype.Results: In the DMD group, the median age at assessment was 8 years [IQR 7-9 years], the median age at disease onset was 3 years [IQR, 2-6 years], and the mean duration of illness was 4 years [IQR, 2.5-5]. DNA sequencing showed deletions in 34/38 (89.5 %) and duplications in 4/38 (10.5%) patients. The median heart rate in DMD children was significantly higher [101.19 (Range, 94.71-108.49)] /min compared to controls [81 (Range, 76.2-92.76)] /min (p < 0.05). All the assessed HRV and BPV parameters were significantly impaired in DMD cases except for the coefficient of variance of systolic blood pressure. Further, BRS parameters were also significantly reduced in DMD, excluding alpha-LF. A positive correlation was found between alpha HF with age at onset and duration of illness. Conclusion: This study demonstrates a distinct early impairment of neuro-cardio-autonomic regulation in DMD. Simple yet effective non-invasive techniques such as HRV, BPV, and BRS may help identify cardiac dysfunction in a pre-clinical state, paving the way for early cardio-protective therapies and limiting disease progression in DMD patients.
引用
收藏
页码:227 / 238
页数:12
相关论文
共 50 条
  • [1] Autonomic dysfunction in patients with Duchenne muscular dystrophy
    Dello Russo, A
    De Luca, L
    De Martino, G
    Messano, L
    Giglio, V
    Mangiola, F
    Damiani, A
    Fumagalli, G
    Lanza, GA
    Bellocci, F
    EUROPEAN HEART JOURNAL, 2000, 21 : 552 - 552
  • [2] Autonomic function in patients with Duchenne muscular dystrophy
    Inoue, Miki
    Mori, Kazuhiro
    Hayabuchi, Yasunobu
    Tatara, Katsunori
    Kagami, Shoji
    PEDIATRICS INTERNATIONAL, 2009, 51 (01) : 33 - 40
  • [3] Cardio-renal syndrome in Duchenne muscular dystrophy
    Wong, B.
    Webb, C.
    Fahey, M.
    Meyer, T.
    Laraja, K.
    Kashtan, C.
    Salerno, A.
    Shellenbarger, K.
    Gupta, N.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S60 - S60
  • [4] Tamoxifen in children with Duchenne muscular dystrophy
    Servais, Laurent
    LANCET NEUROLOGY, 2023, 22 (10): : 872 - 873
  • [5] How are the Children with Duchenne Muscular Dystrophy?
    Lessky-Hoehl, Renate
    Rappold, Mika
    PADIATRIE UND PADOLOGIE, 2021, 56 (04): : 148 - 149
  • [6] Kinesthesia in children with Duchenne muscular dystrophy
    Akel, B.
    Karayazgan, S.
    Subasi, S.
    Bulut, N.
    Yilmaz, O.
    Karaduman, A.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S303 - S303
  • [7] Duchenne muscular dystrophy: Survival by cardio-respiratory interventions
    Ishikawa, Yuka
    Miura, Toshihiko
    Ishikawa, Yukitoshi
    Aoyagi, Tomoyuki
    Ogata, Hitoko
    Hamada, Satoshi
    Minami, Ryoji
    NEUROMUSCULAR DISORDERS, 2011, 21 (01) : 47 - 51
  • [8] AUTONOMIC FUNCTION AND THE SINUS TACHYCARDIA OF DUCHENNE MUSCULAR-DYSTROPHY
    MILLER, G
    DORSOGNA, L
    OSHEA, JP
    BRAIN & DEVELOPMENT, 1989, 11 (04): : 247 - 250
  • [9] Disabilities in children with Duchenne muscular dystrophy: A profile
    Nair, KPS
    Vasanth, A
    Gourie-Devi, M
    Taly, AB
    Rao, S
    Gayathri, N
    Murali, T
    JOURNAL OF REHABILITATION MEDICINE, 2001, 33 (04) : 147 - 149
  • [10] Memory deficit of children with Duchenne muscular dystrophy
    Parisi, L.
    Firrigno, L.
    Bisconti, G.
    Di Filippo, T.
    Testa, D.
    Roccella, M.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 866 - 867